Overview
Primary malignant neoplasms of the sacrum are rare but aggressive tumors that pose significant diagnostic and therapeutic challenges. These tumors often present with nonspecific symptoms, complicating early detection and accurate diagnosis. Common histologies include chordomas, chondrosarcomas, and various types of sarcomas, with chordomas comprising a substantial proportion of cases, as evidenced by a study reporting that 82.4% of sacral malignancies were chordomas in a cohort of 34 patients [PMID:21637135]. The management of these tumors frequently involves complex surgical resections, such as sacrectomy, coupled with reconstructive strategies to mitigate functional deficits and improve quality of life. Understanding the epidemiology, clinical presentation, diagnostic approaches, and comprehensive management strategies is crucial for optimizing patient outcomes.
Epidemiology
Primary malignant neoplasms of the sacrum are relatively uncommon, with reported incidence rates varying across different studies. A notable study included 34 patients with a mean age of 50.1 years (standard deviation, 16.0 years), highlighting the broad age range affected by these tumors [PMID:21637135]. Chordomas were the predominant histopathological subtype, accounting for 82.4% of cases, underscoring their significant representation in sacral malignancies. These tumors can arise at any age but tend to present more frequently in middle-aged adults, suggesting potential genetic or environmental factors influencing their development. The rarity of these tumors often necessitates multidisciplinary approaches for both diagnosis and treatment, involving orthopedic surgeons, oncologists, and reconstructive specialists.
Clinical Presentation
Patients with primary malignant neoplasms of the sacrum often present with a constellation of symptoms that can be nonspecific and evolve over time. Common clinical manifestations include intractable pain, which can radiate to the lower extremities and affect daily activities significantly. For instance, a case report detailed a 52-year-old patient experiencing severe pain due to a malignant fibrous histiocytoma involving the L5 vertebral segment and sacrum, emphasizing the clinical significance of persistent pain as a critical symptom [PMID:20644377]. Additionally, pelvic floor dysfunction, characterized by symptoms such as incontinence and impaired rectal function, significantly impacts patients' quality of life post-surgery. A study highlighted that pelvic floor dysfunction, particularly incontinence, markedly affects functional outcomes and patient satisfaction following sacrectomy, necessitating comprehensive pre- and post-operative management strategies [PMID:40865012]. These symptoms underscore the importance of thorough clinical evaluation and early intervention to address both the primary tumor and its secondary effects on adjacent structures.
Diagnosis
Accurate diagnosis of primary malignant neoplasms of the sacrum relies heavily on a combination of clinical assessment and advanced imaging techniques. Radiographic studies, including plain X-rays, computed tomography (CT), and magnetic resonance imaging (MRI), play pivotal roles in delineating tumor extent, local invasion, and involvement of adjacent structures. A study emphasized the critical role of imaging in diagnosing and planning complex resections, illustrating how detailed imaging facilitated surgical technique and outcome assessment [PMID:20644377]. MRI, in particular, provides high-resolution images that help differentiate between various histological types and assess the relationship of the tumor with neural structures and bone, crucial for surgical planning. Biopsy confirmation is essential for definitive histopathological diagnosis, often guided by imaging findings to target suspicious areas accurately. In clinical practice, a multidisciplinary approach involving radiologists, pathologists, and surgeons ensures comprehensive evaluation and precise diagnosis, critical for tailoring appropriate treatment strategies.
Management
The management of primary malignant neoplasms of the sacrum typically involves a multimodal approach, encompassing surgical resection, reconstructive techniques, and adjuvant therapies. Surgical resection, often requiring en bloc sacrectomy, aims to achieve clear margins and remove the tumor comprehensively. Innovative reconstructive strategies are essential to address the significant soft-tissue defects post-resection. Studies have demonstrated the efficacy of using flaps such as HADM (hemi-abdominal dermal myocutaneous) and gluteus maximus myocutaneous flaps, which have shown acceptable rates of wound complications and favorable functional outcomes [PMID:21637135]. For instance, in a cohort of 34 patients, these reconstructive methods minimized parasacral hernia incidence, highlighting their role in preserving pelvic function and reducing morbidity. Additionally, the incorporation of synthetic mesh in pelvic floor reconstruction has shown promising results, with patients demonstrating significantly better quality of life scores in physical functioning, general health, and vitality, as measured by the SF-36 survey [PMID:40865012]. However, mesh use should be carefully considered, particularly in cases of chronic infection, severe pelvic adhesions, or patient-specific contraindications.
Adjuvant therapies, including radiation and chemotherapy, are often integrated based on tumor histology and stage. For example, chordomas may benefit from proton beam radiation post-surgery, while sarcomas might require systemic chemotherapy in addition to surgical intervention. The choice of adjuvant therapy should be individualized, guided by multidisciplinary tumor board discussions to optimize treatment efficacy and minimize side effects. Postoperative follow-up is crucial, involving regular imaging and clinical assessments to monitor for recurrence and manage complications effectively. Long-term follow-up data from studies indicate favorable outcomes with a median follow-up period of 45.7 months, reporting only one asymptomatic parasacral hernia, underscoring the importance of meticulous surgical technique and reconstructive planning [PMID:21637135].
Complications
Despite advancements in surgical techniques and reconstructive strategies, primary malignant neoplasms of the sacrum carry significant risks of complications that can profoundly affect patient outcomes. Wound-related complications, such as dehiscence, are notable, with studies reporting that approximately 20.6% of patients experienced wound dehiscence, often associated with factors like estimated blood loss exceeding 1500 mL, prolonged operative times (>9 hours), and postoperative bowel incontinence [PMID:21637135]. These factors highlight the need for meticulous surgical execution and vigilant postoperative care to mitigate such risks. Vascular injuries, including those affecting venous structures, and flap viability issues, as seen in a case report involving a nonviable myocutaneous flap, further underscore the complexity of these surgeries [PMID:20644377]. Additionally, while synthetic mesh reconstruction has shown benefits in quality of life metrics, specific complication rates between mesh and non-mesh groups have not shown clinically significant differences, though detailed complication profiles remain areas for further investigation [PMID:40865012]. Comprehensive perioperative management, including meticulous surgical technique, vigilant monitoring, and prompt intervention for complications, is essential to optimize patient recovery and outcomes.
Prognosis & Follow-up
The prognosis for patients with primary malignant neoplasms of the sacrum varies significantly based on tumor histology, stage at diagnosis, and the effectiveness of treatment modalities employed. While surgical resection and reconstructive strategies can lead to favorable long-term outcomes, as evidenced by studies reporting minimal parasacral hernia incidence with a median follow-up of 45.7 months [PMID:21637135], metastatic disease remains a critical concern. A case study highlighted that despite complete resolution of local symptoms postoperatively, metastatic spread led to mortality within five months, emphasizing the importance of vigilant follow-up for early detection of distant metastases [PMID:20644377]. Regular follow-up protocols typically include periodic imaging (CT, MRI) and clinical assessments to monitor for recurrence and manage any emerging complications. Quality of life assessments, such as the SF-36 survey, provide valuable insights into functional outcomes, with mesh reconstruction showing trends towards improved pelvic floor function and overall quality of life [PMID:40865012]. Comprehensive follow-up care, integrating both clinical and patient-reported outcomes, is crucial for optimizing long-term survival and functional status.
Key Recommendations
These recommendations aim to provide a structured approach to managing primary malignant neoplasms of the sacrum, balancing aggressive treatment with functional preservation and quality of life improvement.
References
1 Yan X, Wang K, Shen Y, Lin N, Huang X, Li H et al.. Synthetic Mesh Reconstruction Improves Pelvic Floor Function and Quality of Life After Sacrectomy: A Preliminary Clinical Assessment. Clinical orthopaedics and related research 2025. link 2 Dasenbrock HH, Clarke MJ, Bydon A, Witham TF, Sciubba DM, Simmons OP et al.. Reconstruction of extensive defects from posterior en bloc resection of sacral tumors with human acellular dermal matrix and gluteus maximus myocutaneous flaps. Neurosurgery 2011. link 3 Gallia GL, Suk I, Witham TF, Gearhart SL, Black JH, Redett RJ et al.. Lumbopelvic reconstruction after combined L5 spondylectomy and total sacrectomy for en bloc resection of a malignant fibrous histiocytoma. Neurosurgery 2010. link